Clinical Trial Update: Cardiovascular Risk Reduction in Epilepsy [NA]

View source ↗

Summary

A UCLA-sponsored clinical trial on cardiovascular risk reduction in epilepsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Hyperlipidemia
• Hypertension

Snippet

Sponsor: University of California, Los Angeles | Conditions: Epilepsy, Hypertension | NA | Status: WITHDRAWN